Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Naturewise Biotech & Medicals's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.58.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Naturewise Biotech & Medicals's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.90.
Naturewise Biotech & Medicals (ROCO:4732) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Naturewise Biotech & Medicals's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Naturewise Biotech & Medicals's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Naturewise Biotech & Medicals Days Inventory Related Terms
Naturewise Biotech & Medicals Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Naturewise Biotech & Medicals Days Inventory Chart
ROCO:4732 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Naturewise Biotech & Medicals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Naturewise Biotech & Medicals Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Naturewise Biotech & Medicals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Naturewise Biotech & Medicals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Naturewise Biotech & Medicals (ROCO:4732) has a Days Inventory of 312.70 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Naturewise Biotech & Medicals and its competitors. This is 12% above median its historical median of 278.46. Over the past decade, Naturewise Biotech & Medicals' Days Inventory has ranged from 119.74 to 356.30. According to the industry distribution chart, Naturewise Biotech & Medicals ranks #457 out of 638 companies in the Biotechnology industry, placing it in the top 71.6%.
Is Naturewise Biotech & Medicals' Days Inventory too high?
Naturewise Biotech & Medicals' current Days Inventory of 312.70 is 12% above median its 10-year median of 278.46. Over the past 10 years, this metric has ranged from a low of 119.74 to a high of 356.30. The Biotechnology industry median Days Inventory is 183.20. Naturewise Biotech & Medicals' value of 312.70 is 70.7% above this industry median. Based on the distribution chart, Naturewise Biotech & Medicals ranks #457 out of 638 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Naturewise Biotech & Medicals has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Naturewise Biotech & Medicals' Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Naturewise Biotech & Medicals ranks #457 out of 638 companies for Days Inventory. This places Naturewise Biotech & Medicals in the lower half of its industry. The industry median Days Inventory is 183.20. Naturewise Biotech & Medicals' value of 312.70 is 70.7% above this benchmark. Historically, Naturewise Biotech & Medicals' own Days Inventory has ranged from 119.74 to 356.30 over the past decade. While the company's 10-year median is 278.46 vs. the industry median of 183.20, Naturewise Biotech & Medicals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Naturewise Biotech & Medicals's current Days Inventory of 312.70 is 70.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Naturewise Biotech & Medicals and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Naturewise Biotech & Medicals's current Days Inventory is 312.70, which is 12% above median its own 10-year median of 278.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naturewise Biotech & Medicals stock overvalued right now?
Based on GuruFocus' analysis, Naturewise Biotech & Medicals (ROCO:4732) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$22.08, compared to a current price of NT$17.20 — trading 22.1% below its estimated fair value. The current Days Inventory is 312.70, which is 12% above median its 10-year median of 278.46 and 70.7% above the Biotechnology industry median of 183.20. Naturewise Biotech & Medicals' overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Naturewise Biotech & Medicals (ROCO:4732), the current Days Inventory is 312.70 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Naturewise Biotech & Medicals (ROCO:4732) Overvalued in 2026?
Based on GuruFocus' analysis, Naturewise Biotech & Medicals stock appears to be undervalued.
The current stock price of NT$17.20 is trading 22.1% below its estimated GF Value™ of NT$22.08.
GuruFocus considers Naturewise Biotech & Medicals to be Modestly Undervalued.
Key valuation signals for ROCO:4732:
Days Inventory: 312.70 (12% above median its 10-year median of 278.46)
GF Value™: NT$22.08 vs. price of NT$17.20 (22.1% below fair value)
Industry Position: 70.7% above the Biotechnology median (#457 of 638)
No single metric tells the full story. See the ROCO:4732 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Naturewise Biotech & Medicals Business Description
Naturewise Biotech & Medicals Corp is a Taiwan-based drug development company that focuses on botanical drug and small molecule therapies. Its products include NBM-BMX Oral Softgel Capsule, Lipocol Forte Capsule, and PPLs Taiwan Green Propolis.
63GF Score
Get the complete analysis for ROCO:4732
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4732 has been successfully added to your 
